Research

Hormonal

Social media platforms (Instagram, TikTok) misrepresent semaglutide by promoting off-label weight loss use while omitting common adverse effects like gastrointestinal disorders, leading to unreflected medication use and supply shortages for indicated patients.

If you are considering semaglutide for weight loss, understand that it is a prescription medication with significant side effects, primarily gastrointestinal issues. Social media often omits these risks. Consult a healthcare provider to ensure it is appropriate for you and to avoid contributing to shortages for diabetic patients.

ModerateRefutesMEDIUM confidence
Semaglutide was presented by social media users almost exclusively for weight reduction. Misrepresentation of the pharmacological properties of semaglutide with respect to mechanism of action, indication, adverse effects, and drug interactions was very common on social media. The important aspect of treatment costs and supply shortages was barely covered, if at all.
Lara Elisabeth Propfe et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2025

Why this rating

The evidence is based on a cross-sectional analysis of social media posts compared to clinical trial data (STEP trials), not a direct clinical trial of the social media intervention itself.

Source

Misrepresentation of semaglutide in social media

Lara Elisabeth Propfe et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2025

DOI 10.1007/s00210-025-04403-5

cross_sectional · n=250Cited 15×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →